FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 331:469-470 August 18, 1994 Number 7 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

In the past few years, new genetic techniques have been used successfully to locate and characterize genes for several types of hereditary hearing loss. The effects of this new knowledge on clinical practice and the lives of people with hearing loss will be far-reaching and controversial. Hearing loss affects an estimated 28 million people in the United States. Hereditary factors account for a considerable proportion of all cases of hearing loss. There are over 200 types of hereditary hearing loss,¹ approximately one third of which are associated with other medical, physical, or developmental abnormalities (known as syndromic hearing loss). For . . . [Full Text of this Article]

References

This article has been cited by other articles:

• Guo, K., Andres, V., Walsh, K. (1998). Nitric Oxide–Induced Downregulation of Cdk2 Activity and Cyclin A Gene Transcription in Vascular Smooth Muscle Cells. Circulation 97: 2066-2072 [Abstract] [Full Text]  
• Maillard, L., Van Belle, E., Smith, R. C, Le Roux, A., Denefle, P., Steg, G., Barry, J. J, Branellec, D., Isner, J. M, Walsh, K. (1997). Percutaneous delivery of the gax gene inhibits vessel stenosis in a rabbit model of balloon angioplasty. Cardiovasc Res 35: 536-546 [Abstract] [Full Text]